What is the primary reason for Teradyne's improved financial performance in the first nine months of 2004?

The primary reason for Teradyne's improved financial performance is a substantial increase in net revenues, particularly driven by a strong rebound in the Semiconductor Test Systems segment. This growth was supported by increased customer demand, especially in the wireless and broadband markets, and a favorable shift in revenue mix towards higher-margin products.

How has Teradyne's liquidity and financial health changed compared to the prior year?

Teradyne's liquidity has significantly improved. Cash, cash equivalents, and marketable securities increased to $675.6 million as of October 3, 2004, compared to a lower combined amount in the prior year. Operating activities generated $197.2 million in cash flow for the nine months ended October 3, 2004, a dramatic improvement from a nearly breakeven result in the prior year, indicating a stronger financial position.

What is the status of Teradyne's restructuring efforts and their financial impact?

Teradyne has continued its restructuring activities, but the financial impact has decreased. For the nine months ended October 3, 2004, restructuring and other charges resulted in a net charge of $0.2 million. This is a significant reduction compared to the $56.2 million charge recorded in the same period of 2003, suggesting that the majority of the restructuring impact has been recognized in prior periods.

Are there any significant legal proceedings that could materially affect Teradyne?

Teradyne is involved in several legal proceedings, including a claim related to past acquisitions and a class-action lawsuit concerning alleged misrepresentations. While the company believes it has meritorious defenses and does not expect these to have a material adverse effect on its consolidated financial position or liquidity, it notes that these could be material to the consolidated results of operations for any single period.

TER 10-Q Filed Nov 12, 2004

Summary

Teradyne, Inc. reported a significant turnaround in its financial performance for the nine months ended October 3, 2004, compared to the same period in the prior year. The company achieved net income of $161.9 million, a substantial improvement from a net loss of $182.5 million in the nine months ended September 28, 2003. This recovery was driven by a strong increase in net revenues, which grew by 42.1% to $1.41 billion, primarily fueled by a 76.1% surge in Semiconductor Test Systems revenue. The balance sheet as of October 3, 2004, showed a healthier financial position with total assets increasing to $1.97 billion from $1.79 billion at the end of 2003. Notably, cash and cash equivalents and marketable securities saw an increase, bolstering liquidity. Despite a strong revenue rebound and improved profitability, the company continued to manage restructuring and other charges, reflecting ongoing efforts to optimize operations.

Key Highlights

1Net income for the nine months ended October 3, 2004, was $161.9 million, a significant improvement from a net loss of $182.5 million in the prior year's comparable period.
2Net revenues increased by 42.1% to $1.41 billion for the first nine months of fiscal 2004, compared to $995.3 million in the prior year.
3The Semiconductor Test Systems segment was the primary growth driver, with net revenues up 76.1% to $934.1 million and net bookings increasing by 68.8%.
4Gross profit margin improved substantially to 41.7% for the nine months ended October 3, 2004, up from 27.3% in the prior year, reflecting increased volume, favorable revenue mix, and cost reductions.
5Cash and cash equivalents and marketable securities increased to $675.6 million as of October 3, 2004, indicating a strong liquidity position.
6The company repurchased $8.5 million of its convertible senior notes, demonstrating active debt management.
7Restructuring and other charges continued, though the net impact for the nine months was a $236,000 charge compared to $56.2 million in the prior year, indicating progress in restructuring efforts.

TERADYNE, INC Quarterly Report for Q3 Ended Oct 3, 2004

Summary

Key Highlights

Frequently Asked Questions